Table: begin end state 1 11 cytoplasmic 12 32 transmembrane 33 48 non-cytoplasmic 49 73 transmembrane 74 79 cytoplasmic 80 99 transmembrane 100 104 non-cytoplasmic 105 126 transmembrane 127 137 cytoplasmic 138 161 transmembrane 162 171 non-cytoplasmic 172 194 transmembrane 195 240 cytoplasmic 241 262 transmembrane 263 273 non-cytoplasmic 274 294 transmembrane 295 304 cytoplasmic 305 324 transmembrane 325 329 non-cytoplasmic 330 350 transmembrane 351 356 cytoplasmic 357 380 transmembrane 381 394 non-cytoplasmic 395 415 transmembrane 416 430 cytoplasmic
Input: >WP_050465826.1 NCBI__GCF_001189915.1:WP_050465826.1 MNEDQLYKRVTLRLIPFLVLLYLIAYIDRSILGFAKLYMNVDVGISDAAYGFGAGLFFLG YILFEVPSNLILVKVGARRWFARIILTWGAITVAMALIQGPTSFYILRFLLGAAEAGFYP GVLYYLTLWYPKQRRGRIYGYFFFAQPLAPLVGGPLAGALLGMNGMLGVHGWQWVFILCG LPAVLLALPTLKLLPEKPQDAKWLTPQEAHWLTSGIERGSAGIAAATKSHSPLQALKNPR VLLLAFAYVPIPLAIYGLSLWLPTLVKAFNASDFTTGVLSAVPFLFGVIGLLIVPRSSDK RNERYGHIIVCTLLAAAGLIGAALSHSLALQLSFLCMTGFGMYSASAVLWTLPSQFLVGT GAAAGLAVINSIGNLGGYLGPFGIGLIKEYTGSLAYGLYFLAASLVLVIVLVLILRAMGE VDKGSAGTSR
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server